RE:RE:RE:RE:RE:RE:RE:BiotechOh so I was right??
Now if you read more about your investment, you'll know that fewer islets in the pouch work better. This trial is about finding the ideal dose. The insulin free patient news was a little misleading for those who don't understand the science. Injecting more islets does not = better results. The question remaining to be asked is what were the patients metrics presented in that chart before they decided to inject into the portal vein? That answer also exists out there and it is not all that great. Barely any reduction in insulin. Only good thing was the number of hypoglycemic episodes were significantly reduced. Hope they are able to dial in the dosage in the remaining patients and get the insulin usage down before using the Shapiro teqnique.